| NDC Code | 63323-723-06 |
|---|
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06) > 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04) |
|---|
| Product NDC | 63323-723 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Remifentanil Hydrochloride |
|---|
| Non-Proprietary Name | Remifentanil Hydrochloride |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20180119 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA206223 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | REMIFENTANIL HYDROCHLORIDE |
|---|
| Strength | 1 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
|---|
| DEA Schedule | CII |
|---|